Advertisement

Ads Placeholder
Loading...

Pfizer Inc.

PFE•NYSE
Healthcare
Drug Manufacturers - General
$28.33
$-0.22(-0.77%)
U.S. Market opens in 3h 59m

Pfizer Inc. (PFE) Stock Overview

Explore Pfizer Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap161.1B
P/E Ratio20.72
EPS (TTM)$1.36
ROE0.09%
Fundamental Analysis

AI Price Forecasts

1 Month$25.57
3 Months$28.17
1 Year Target$26.26

PFE Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Pfizer Inc. (PFE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 61.72, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $26.26.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 20.72 and a market capitalization of 161.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.77%
5-Day Change
2.16%
1-Month Change
6.58%
3-Month Change
12.51%
6-Month Change
3.51%
Year-to-Date (YTD) Change
12.51%
1-Year Change
16.63%
3-Year Change
-31.49%
5-Year Change
-21.91%
All-Time (Max) Change
6495.58%

Contact Information

https://www.pfizer.com
212 733 2323
66 Hudson Boulevard East, New York City, NY, 10001-2192

Company Facts

810,000 Employees
IPO DateJun 1, 1972
CountryUS
Actively Trading

Frequently Asked Questions